News | November 18, 2014

ASTRO Commends Medicare’s Decision to Cover Annual, Low-Dose CT Screenings

Screenings will benefit patients who have the highest risk of developing lung cancer

Lung cancer, ASTRO, CT Screen, National Lung Screening Trial

Image Courtesy of GE

November 18, 2014 — The American Society for Radiation Oncology (ASTRO) is supporting the Centers for Medicare and Medicaid Services' (CMS) decision to provide coverage for annual lung cancer screening via a low-dose CT screening for those at the highest-risk for lung cancer.  

The Proposed Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N) confirms that there is sufficient evidence to warrant annual lung cancer screening for patients most at risk for developing lung cancer.

The patient criteria for eligibility is as follows: aged 55 to 74; asymptomatic (no signs or symptoms of lung disease); a smoking history of at least 30 pack-years (one pack-year = smoking one pack per day for one year; 1 pack = 20 cigarettes); or a current smoker or someone who has quit smoking within the last 15 years.

Bruce G. Haffty, M.D., ASTRO chair, FASTRO remarks that lung cancer is the leading cause of cancer death for both men and women in the United States, with more than 160,000 people each year dying from the disease. This surpasses the number of deaths from breast, colon and prostate cancers combined. “With this annual screening in place, we will be able to diagnose patients earlier when treatment can be most successful, which will save thousands of lives,” Haffty says.

CMS’s decision follows the United States Preventive Task Force’s December 2013 recommendation that LDCT is a Grade B screening.

For more information: www.astro.org

Related Content

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...